United States· US:71403-003_d743c06d-1277-4504-803b-5752af09ba03
Rhofade
A oxymetazoline product containing oxymetazoline hydrochloride, registered in United States by EPI Health, LLC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- OXYMETAZOLINE HYDROCHLORIDE
- Manufacturer
- EPI Health, LLC
- Country
- United States (US)
- ATC code
- D11AX27
- ATC class
- Oxymetazoline
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc1171403003151 TUBE in 1 CARTON (71403-003-15) / 3 g in 1 TUBE
- ndc1171403003301 TUBE in 1 CARTON (71403-003-30) / 30 g in 1 TUBE
- ndc1171403-003-15
- ndc1171403-003-30
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
51 interactions on record for oxymetazoline.
Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Oxymetazoline · interactions on record
51 records
- 5 severe
- 46 moderate
Most severe, free to view
- MethylergometrineG02AB01severe
- ErgometrineG02AB03severe
- DihydroergotamineN02CA01severe
- ErgotamineN02CA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Oxymetazoline in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainAFRIN AROMA MANZANILLA 0,5 MG/ML SOLUCION PARA PULVERIZACION NASALBayer Hispania S.L.
- PolandAcatar CareUS Pharmacia Sp. z o.o.
- SwedenNasin 0,25 mg/ml Nässpray, lösningPerrigo Sverige AB
- CanadaCLARITIN ALLERGY DECONGESTANTBAYER INC
- United KingdomAfrazine 0.05% nasal spraySchering-Plough Ltd
- NetherlandsAfrin 0,5 mg/ml neusspray, oplossingBayer B.V.
- CzechiaAFRINBAYER s.r.o., Praha
- BelgiumNesivine 0,01 % Baby Sine ConservansP&G Health Belgium
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Wick Nasiben Baby Sanft, Wick Nasivin Aloe & Eukalyptus
- Belgium · Nesivine, Nesivine Baby Sine Conservans
- Bulgaria · Vicks Sinex Aloe And Eucalyptus, Африн
- Czechia · Afrin, Afrin S Mentolem
- Germany · Nasivin Erwachsene Und Schulkinder, Nasivin Für Erwachsene Und Schulkinder
- Estonia · Afrin, Afrin Menthol
- Spain · Antirrinum Adultos Nueva Fórmula, Cuvenax
- Finland · Vicks, Vicks Sinex
- France · Chlorhydrate D'oxymétazoline Eg, Pernazene
- United Kingdom (Northern Ireland) · Blocked Nose Relief, Boots Decongestant
- Greece · Ezixin, Ronal
- Croatia · Nazopass, Operil P Za Djecu
- Hungary · Afrin, Afrin Comfort Mentollal
- Ireland · Vicks Sinex Micromist
- Iceland · Nezeril
- Italy · Equimet, Froben Raffreddore
- Lithuania · Afrin, Afrin Menthol
- Luxembourg · Nesivine, Nesivine Baby Sine Conservans
- Latvia · Afrin, Sinex
- Malta · Utabon Adults, Utabon Pediatric
- Netherlands · Afrin, Afrin Met Glycerol
- Norway · Rhinox
- Poland · Acatar Care, Acatar Care Kids
- Portugal · Alerjon, Bisolspray Nebulicina Adulto
- Romania · Afrin, Afrin Mentol
- Sweden · Nasin, Nezebi
- Slovenia · Afrin, Nazopass
- Slovakia · Afrin, Afrin S Mentolom
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c4f51cb9-72de-4126-b3f7-f53360d05fbe GET /v1/drugs/c4f51cb9-72de-4126-b3f7-f53360d05fbe?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "1",
"substance": "OXYMETAZOLINE HYDROCHLORIDE",
"productndc": "71403-003",
"dosage_form": "CREAM",
"dea_schedule": null,
"strength_unit": "g/100g",
"application_number": "NDA208552",
"marketing_category": "NDA"
}See everything about oxymetazoline.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.